Viral Vector And Plasmid DNA Manufacturing Market Forecast and Industry Insights
The viral vector and plasmid DNA manufacturing market is being shaped by the commercialization of advanced therapies. Valued at USD 6.46 billion in 2025, the market is projected to reach USD 7.36 billion in 2026 and USD 21.28 billion by 2034, growing at a CAGR of 14.16% during the forecast period 2026–2034. Europe led in 2025 with a 42.0% share. Rising investment in gene therapy...
0 Comments 0 Shares 33 Views 0 Reviews